Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Name: Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
SKU: 2766
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: eduard-parellada, ethnicityrace, health-disparities, illness-characteristics, ipolar-disorder, md, msc, phd

Description

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Description

Eduard Parellada, MD, MSc, PhD

DRUG DISPOSITION & PHARMACOKINETICS

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

Eduard Parellada, MD, MSc, PhD

Related products

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?